Bank of Montreal
LXRX icon

Bank of Montreal’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bank of Montreal’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-25,000
Closed -$157K – 4880
2019
Q2 		$157K Hold
25,000
– – ﹤0.01% 3061
2019
Q1 		$139K Buy
+25,000
New +$152K ﹤0.01% 2917

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of Montreal's LXRX Position: Q1 2026 in Review

Bank of Montreal held its Lexicon Pharmaceuticals (LXRX) position steady in Q1 2026 at 70,000 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #3115.

Bank of Montreal first reported a position in LXRX in Q2 2014 and has held it in 35 quarters since. The position peaked at $1.64M in Q4 2016. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Bank of Montreal held 70,000 shares of Lexicon Pharmaceuticals worth $109K as of Q1 2026.
  • Bank of Montreal left its Lexicon Pharmaceuticals share count unchanged in Q1 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #3115 holding.
  • Bank of Montreal first reported a position in Lexicon Pharmaceuticals in Q2 2014 and has held it in 35 quarters since.
  • Bank of Montreal's Lexicon Pharmaceuticals position peaked at $1.64M in Q4 2016.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.